C. Lanzarotti

Drug–drug interaction profile of components of a fixed combination of netupitant and palonosetron: Review of clinical data

S. Calcagnile, J. Natale, G. Rossi, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Evaluation of the effect of food and age on the pharmacokinetics of oral netupitant and palonosetron in healthy subjects: A randomized, open‐label, crossover phase 1 study

M. Gutacker, S. Calcagnile, W. Timmer, 2015, Clinical pharmacology in drug development.

Netupitant PET imaging and ADME studies in humans

C. Giuliano, S. Calcagnile, L. Stevens, 2013, Journal of clinical pharmacology.

Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of midazolam, erythromycin, and dexamethasone

G. Rossi, C. Lanzarotti, 2013, Supportive Care in Cancer.

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

M. Aapro, A. Dechaphunkul, S. Lu, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase 1 pharmacokinetic study of oral NEPA, the fixed combination of netupitant and palonosetron, in Chinese healthy volunteers

P. Hu, A. Bernareggi, S. Chessari, 2021, Cancer Chemotherapy and Pharmacology.

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

Jian-hua Chang, Wei Li, Dong Wang, 2020, Cancer medicine.

Pharmacokinetics and safety evaluation of oral Palonosetron in Chinese healthy volunteers: A phase 1, open-label, randomized, cross-over study.

P. Hu, A. Bernareggi, S. Chessari, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of palonosetron and impact of the fixed dose combination of netupitant and palonosetron when coadministered with ketoconazole, rifampicin, and oral contraceptives

S. Calcagnile, K. Kammerer, W. Timmer, 2013, Supportive Care in Cancer.